Starpharma Holdings Ltd
Level 6, Baker Heart Research Building
Commercial Road
Melbourne
VIC 3004
Tel: 61-3-8532-2700
Fax: 61-3-9510-5955
Website: http://www.starpharma.com/
Email: info@starpharma.com
124 articles about Starpharma Holdings Ltd
-
Starpharma Release: Enrolment Complete For Phase 3 VivaGel BV-R Program
10/13/2016
-
Starpharma Release: VivaGel Condom Receives Regulatory Approval In Canada
9/13/2016
-
Starpharma Initiates New DEP Drug Delivery Program With AstraZeneca PLC
7/28/2016
-
Starpharma Signs License For A VivaGel Condom In China
7/21/2016
-
Australia's Starpharma, Ansell To Supply Anti-Zika Condoms For Olympics
5/16/2016
-
Starpharma Release: VivaGel Active Against Zika Virus
5/5/2016
-
Starpharma Release: DEP Cabazitaxel Shows Complete And Sustained Tumour Regression In Breast Cancer Model
4/4/2016
-
Adama Licenses Starpharma 's Priostar Dendrimer Technology For The Development And Commercialization Of A Novel 2,4-D Product For The U.S. Market
3/17/2016
-
Starpharma Licences VivaGel BV To Aspen Pharmacare For ANZ
3/4/2016
-
Starpharma Interim Report And Half-Year Financial Results
2/17/2016
-
Starpharma Signs MOU For VivaGel Condom In China
12/16/2015
-
Starpharma Completes A $32 Million Placement - SPP To Follow
12/9/2015
-
Starpharma Release: Second DEP Candidate Selected By AstraZeneca PLC
12/2/2015
-
Starpharma 's Targeted DEP Outperforms Leading Treatments In Ovarian Cancer Model
11/16/2015
-
Starpharma Release: EU Marketing Approval Granted For VivaGel BV
9/24/2015
-
AstraZeneca PLC And Starpharma Ink Drug Delivery Deal Worth up to $450 Million
9/8/2015
-
Starpharma Holdings Ltd CEO Dr. Jackie Fairley To Be Interviewed Live On Iheart Radio/ Clear Channel Atlanta Studios - 640 WGST AM's
2/17/2015
-
FDA Green Lights Starpharma Holdings Ltd's VivaGel Trial Design
7/14/2014
-
Rob Thomas Succeeds Retiring Starpharma Holdings Ltd Chairman Peter Bartels
6/13/2014
-
Starpharma Holdings Ltd's Clinical Trial Programs Accelerating
6/5/2014